QQQ | VEGN | QQQ / VEGN | |
Gain YTD | 31.402 | 29.753 | 106% |
Net Assets | 332B | 112M | 296,429% |
Total Expense Ratio | N/A | N/A | - |
Turnover | 22.08 | 20.00 | 110% |
Yield | 0.59 | 0.58 | 102% |
Fund Existence | 26 years | 5 years | - |
QQQ | VEGN | |
---|---|---|
RSI ODDS (%) | 2 days ago90% | 2 days ago80% |
Stochastic ODDS (%) | 2 days ago84% | 2 days ago64% |
Momentum ODDS (%) | 2 days ago90% | 2 days ago90% |
MACD ODDS (%) | 2 days ago87% | 2 days ago73% |
TrendWeek ODDS (%) | 2 days ago90% | 2 days ago88% |
TrendMonth ODDS (%) | 2 days ago89% | 2 days ago87% |
Advances ODDS (%) | 3 days ago90% | 3 days ago88% |
Declines ODDS (%) | 9 days ago80% | 9 days ago74% |
BollingerBands ODDS (%) | 2 days ago81% | 2 days ago78% |
Aroon ODDS (%) | 2 days ago90% | 2 days ago90% |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
BHSRX | 61.42 | N/A | N/A |
BlackRock Health Sciences Opps R | |||
GCCLX | 18.92 | -0.02 | -0.11% |
GMO Climate Change I | |||
READX | 12.29 | -0.06 | -0.49% |
Lazard Emerging Markets Eq Advtg R6 | |||
FDGCX | 22.16 | -0.24 | -1.07% |
Fidelity Advisor Dividend Growth C | |||
CLTIX | 15.65 | -0.20 | -1.26% |
Catalyst/Lyons Tactical Allocation I |
A.I.dvisor indicates that over the last year, VEGN has been loosely correlated with VRT. These tickers have moved in lockstep 63% of the time. This A.I.-generated data suggests there is some statistical probability that if VEGN jumps, then VRT could also see price increases.
Ticker / NAME | Correlation To VEGN | 1D Price Change % | ||
---|---|---|---|---|
VEGN | 100% | -0.63% | ||
VRT - VEGN | 63% Loosely correlated | -4.19% | ||
DKNG - VEGN | 53% Loosely correlated | +3.77% | ||
CARR - VEGN | 52% Loosely correlated | -1.83% | ||
TT - VEGN | 52% Loosely correlated | -1.65% | ||
HOOD - VEGN | 49% Loosely correlated | -3.63% | ||
More |